查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986703

全球神經診斷市場：市場規模、佔有率和趨勢分析（按技術、最終用途和地區分類），細分市場預測（2026-2033 年）

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies (Computed Tomography, Magnetic Resonance Imaging)), By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

神經診斷市場概述

全球神經診斷市場預計到 2025 年將達到 190.1 億美元，預計到 2033 年將達到 365.7 億美元，2026 年至 2033 年的複合年成長率為 8.52%。

這一成長主要由癲癇、阿茲海默症、帕金森氏症、中風和憂鬱症神經系統疾病的日益普遍所驅動，這些疾病對準確和早期診斷解決方案的需求持續成長。

此外，由於老年人更容易患神經退化性疾病和腦血管疾病，老年人口的成長也大大促進了市場擴張。

人工智慧整合成像、攜帶式腦電圖 (EEG) 設備以及高解析度 MRI 和 CT 系統等技術的進步正在提高診斷準確性和工作流程效率，進一步加速了這些技術在醫院和診斷中心的普及應用。

神經影像技術的進步以及市場主要參與者推出的創新技術預計將進一步推動市場成長。例如，西門子醫療於2025年1月在清奈舉行的2025年亞太放射學會（AOCR）年會上發布了最新的診斷影像技術創新成果，進一步彰顯了其致力於透過安全、便利、靈活和永續的技術變革醫療保健，從而改善患者照護的承諾。

此次展覽展出了採用乾式冷卻技術且幾乎無需氦氣的1.5T MAGNETOM Flow磁振造影系統、SOMATOM Pro雙源CT掃描儀、本地生產的MULTIX Impact E數位X光系統以及搭載人工智慧的ACUSON Maple和ACUSON Sequoia超音波系統。這些解決方案旨在提高診斷準確性、簡化工作流程並擴大高品質診斷影像的覆蓋範圍，尤其是在各種不同的醫療環境中。

憂鬱症正在推動神經診斷產業的成長。全球憂鬱症負擔日益加重，促使人們對磁振造影（MRI）、正子斷層掃描（PET）和腦電圖（EEG）等客觀腦部評估工具的需求不斷成長，以闡明疾病機制、支持研究並指南治療方法的選擇。由於憂鬱症是全球重要的精神疾病，也是導致殘疾的主要原因之一，因此臨床和研究領域對先進的神經系統評估技術有著持續的需求。神經影像學和神經生理學技術正被用於研究腦迴路的變化、識別生物標記並開發個人化治療方法，從而直接拓展了神經診斷設備和服務的應用範圍。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：神經學診斷市場：影響因素、趨勢與範圍

  • 市場概況/未來展望
  • 市場規模和成長前景
  • 市場動態
  • 神經診斷市場分析工具
    • 波特五力分析
    • PESTEL 分析

第4章：神經診斷市場：依技術分類的估算與趨勢分析

  • 神經診斷市場：按技術分類的波動分析（單位：百萬美元，2025-2033 年）
  • 神經影像技術
    • 電腦斷層掃描（CT）
    • 磁振造影（MRI）
    • 核子醫學影像（PET、SPECT）
    • 近紅外線光光譜成像（NIRS）
    • 腦電圖（EEG）
    • 腦磁圖（MEG）
    • 基於體素的形態測量（VBM）
  • 體外診斷
  • 神經資訊學

第5章：神經診斷市場：依最終用途分類的估算與趨勢分析

  • 神經診斷市場：按最終用途分類的波動分析（單位：百萬美元，2025-2033 年）
  • 醫院和診所
  • 診斷檢查室
  • 診斷影像中心
  • 其他

第6章：神經診斷市場：區域估算和趨勢分析（按技術和最終用途分類）

  • 神經診斷市場：按地區分類的市場佔有率（單位：百萬美元，2025-2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第7章 競爭情勢

  • 近期趨勢及影響分析：依主要市場參與企業
  • 公司分類
  • 企業市場占有率分析（2025 年）
  • 公司簡介
    • Canon Medical Systems Corporation
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Thermo Fisher Scientific, Inc.
    • FUJIFILM Corporation
    • Natus Medical Incorporated（ARCHIMED）
    • Lifelines Neuro（SIDIS）
    • Advanced Brain Monitoring, Inc.
    • NIHON KOHDEN CORPORATION.
    • F. Hoffmann-La Roche Ltd
    • GE HealthCare.
    • Mitsar Co. LTD.
    • Deymed Diagnostic
    • Neurosoft
    • Cadwell Industries
    • Compumedics Limited
Product Code: GVR-1-68038-277-8

Neurodiagnostics Market Summary

The global neurodiagnostics market size was estimated at USD 19.01 billion in 2025 and is projected to reach USD 36.57 billion by 2033, growing at a CAGR of 8.52% from 2026 to 2033. This growth is primarily driven by the increasing prevalence of neurological disorders such as epilepsy, Alzheimer's disease, Parkinson's disease, stroke, and depression, which are creating sustained demand for accurate and early diagnostic solutions.

In addition, the rising geriatric population is significantly contributing to market expansion, as elderly individuals are more susceptible to neurodegenerative and cerebrovascular diseases.

Technological advancements such as AI-integrated imaging, portable EEG devices, and high-resolution MRI and CT systems are improving diagnostic accuracy and workflow efficiency, further accelerating adoption across hospitals and diagnostic centers.

The advancements in neuroimaging technologies and the launch of new and innovative technologies by the key players in the market are further anticipated to drive market growth. For instance, in January 2025, Siemens Healthineers unveiled its latest diagnostic imaging innovations at the Asian Oceanian Congress of Radiology (AOCR) 2025 held in Chennai, strengthening its commitment to transforming healthcare through safe, accessible, flexible, and sustainable technologies that support improved patient care.

The showcase featured the Dry Cool technology-enabled, virtually helium-free 1.5T MAGNETOM Flow MRI, the Dual Source CT scanner SOMATOM Pro. Pulse, the locally manufactured Digital X-ray system MULTIX Impact E, and AI-powered ultrasound systems ACUSON Maple and ACUSON Sequoia. These solutions are designed to enhance diagnostic accuracy, improve workflow efficiency, and expand access to high-quality imaging, particularly across diverse healthcare settings.

Depression drives growth in the neurodiagnostic industry. The rising global burden of depressive disorders is increasing demand for objective brain-based evaluation tools such as MRI, PET, and EEG to better understand disease mechanisms, support research, and guide treatment selection. Depression is a significant mental health disorder worldwide and a leading cause of disability, creating sustained clinical and research demand for advanced neurological assessment technologies. Neuroimaging and neurophysiological techniques are used to study brain circuit changes, identify biomarkers, and support the development of personalized therapies, which directly expands the use of neurodiagnostic equipment and services.

Global Neurodiagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurodiagnostics market report based on technology, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Neuroimaging Technologies
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Nuclear Medicine Imaging (PET, SPECT)
    • Near infrared spectroscopic imaging (NIRS)
    • Electro-encephalography (EEG)
    • Magneto-encephalography (MEG)
    • Voxel based morphometry (VBM)
  • In Vitro Diagnostics
  • Neuroinformatics
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Imaging Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising prevalence of neurological disorders
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Government and private sector funding
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High cost of equipment and procedures
      • 3.3.2.2. Limited reimbursement in emerging economies
    • 3.3.3. Market Opportunity Analysis
      • 3.3.3.1. Emergence of portable and point-of-care neurodiagnostic devices
      • 3.3.3.2. Rising adoption in emerging markets
    • 3.3.4. Market Challenge Analysis
      • 3.3.4.1. Data privacy and integration issues
  • 3.4. Neurodiagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurodiagnostics Market: Technology Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Neuroimaging Technologies
    • 4.3.1. Neuroimaging Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Computed Tomography (CT)
      • 4.3.2.1. Computed Tomography (CT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Magnetic Resonance Imaging (MRI)
      • 4.3.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Nuclear Medicine Imaging (PET, SPECT)
      • 4.3.4.1. Nuclear Medicine Imaging (PET, SPECT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Near infrared spectroscopic imaging (NIRS)
      • 4.3.5.1. Near infrared spectroscopic imaging (NIRS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.6. Electro-encephalography (EEG)
      • 4.3.6.1. Electro-encephalography (EEG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.7. Magneto-encephalography (MEG)
      • 4.3.7.1. Magneto-encephalography (MEG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.8. Voxel based morphometry (VBM)
      • 4.3.8.1. Voxel based morphometry (VBM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. In Vitro Diagnostics
    • 4.4.1. In Vitro Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Neuroinformatics
    • 4.5.1. Neuroinformatics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurodiagnostics Market: End Use Movement Analysis, USD Million, 2025 & 2033
  • 5.3. Hospitals and Clinics
    • 5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Imaging Centers
    • 5.5.1. Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis, by Technology and by End Use

  • 6.1. Neurodiagnostics Market Share, By Region, 2025 & 2033, USD Million
  • 6.2. North America
    • 6.2.1. North America Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Share Analysis, 2025
  • 7.4. Company Profiles
    • 7.4.1. Canon Medical Systems Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Siemens Healthineers AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Koninklijke Philips N.V.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. FUJIFILM Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Natus Medical Incorporated (ARCHIMED)
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Lifelines Neuro (SIDIS)
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Advanced Brain Monitoring, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. NIHON KOHDEN CORPORATION.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. F. Hoffmann-La Roche Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. GE HealthCare.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Mitsar Co. LTD.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. Deymed Diagnostic
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
    • 7.4.14. Neurosoft
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/ Strategic Initiatives
    • 7.4.15. Cadwell Industries
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/ Strategic Initiatives
    • 7.4.16. Compumedics Limited
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 3 North America Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 4 North America Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 5 U.S. Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 6 U.S. Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 7 Canada Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 8 Canada Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 9 Mexico Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 10 Mexico Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 11 Europe Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 12 Europe Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 13 Europe Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 14 Germany Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 15 Germany Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 16 UK Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 17 UK Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 18 France Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 19 France Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 20 Italy Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 21 Italy Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 22 Spain Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 23 Spain Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 24 Denmark Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 25 Denmark Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 26 Sweden Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 27 Sweden Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 28 Norway Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 29 Norway Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 30 Asia Pacific Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 31 Asia Pacific Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 32 Asia Pacific Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 33 China Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 34 China Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 35 Japan Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 36 Japan Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 37 India Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 38 India Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 39 South Korea Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 40 South Korea Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 41 Australia Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 42 Australia Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 43 Thailand Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 44 Thailand Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 45 Latin America Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 46 Latin America Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 47 Latin America Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 48 Brazil Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 49 Brazil Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 50 Argentina Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 51 Argentina Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 52 MEA Neurodiagnostics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 53 MEA Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 54 MEA Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 55 South Africa Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 56 South Africa Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 57 Saudi Arabia Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 58 Saudi Arabia Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 59 UAE Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 60 UAE Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
  • Table 61 Kuwait Neurodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
  • Table 62 Kuwait Neurodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Neurodiagnostics Market: Market Outlook
  • Fig. 9 Neurodiagnostics Competitive Insights
  • Fig. 10 Parent Market Outlook
  • Fig. 11 Related/Ancillary Market Outlook
  • Fig. 12 Penetration And Growth Prospect Mapping
  • Fig. 13 Industry Value Chain Analysis
  • Fig. 14 Neurodiagnostics Market Driver Impact
  • Fig. 15 Neurodiagnostics Market Restraint Impact
  • Fig. 16 Neurodiagnostics Market Strategic Initiatives Analysis
  • Fig. 17 Neurodiagnostics Market: Technology Movement Analysis
  • Fig. 18 Neurodiagnostics Market: Technology Outlook And Key Takeaways
  • Fig. 19 Technology Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 20 Neuroimaging Technologies Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 21 Computed Tomography (CT) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 22 Magnetic Resonance Imaging (MRI) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 23 Nuclear Medicine Imaging (PET, SPECT) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 24 Near Infrared Spectroscopic Imaging (NIRS) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 25 Electro-Encephalography (EEG) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 26 Magneto-Encephalography (MEG) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 27 Voxel Based Morphometry (VBM) Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 28 In Vitro Diagnostics Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 29 Neuroinformatics Market Estimates And Forecast, 2021 - 2033 (USD Billion)
  • Fig. 30 Neurodiagnostics Market: End Use Movement Analysis
  • Fig. 31 Neurodiagnostics Market: End Use Outlook And Key Takeaways
  • Fig. 32 Hospitals & Clinics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 33 Diagnostic Laboratories Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 34 Imaging Centers Market Estimates And Forecasts,2021 - 2033 (USD Billion)
  • Fig. 35 Others Market Estimates And Forecasts,2021 - 2033 (USD Billion)
  • Fig. 36 North America Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 37 U.S. Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 38 Canada Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 39 Mexico Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 40 Europe Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 41 UK Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 42 Germany Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 43 France Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 44 Italy Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 45 Spain Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 46 Denmark Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 47 Sweden Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 48 Norway Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 49 Asia Pacific Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 50 China Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 51 Japan Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 52 India Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 53 Thailand Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 South Korea Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 55 Australia Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 56 Latin America Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 57 Brazil Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 58 Argentina Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 59 Middle East And Africa Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 60 South Africa Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 61 Saudi Arabia Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 62 UAE Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 63 Kuwait Neurodiagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 64 Market Share of Key Market Players- Neurodiagnostics Market